However, we showed that the level of TNF-α secretion from TLR2 ligands-stimulated PBMCs was slightly lower in AD patients, while the mRNA level of TNF-α elevated dramatically, implying that TLR2 signaling could be amplified in AD patients at the transcriptional level. Here, TNF is linked to Alzheimer disease.